Biosimilars Market is Estimated to Reach USD 88.9 Billion by 2032 | SkyQuest Technology Consulting
The global biosimilars market is driven by less expensive alternatives made possible by the major biologics' patents expiring. The demand for reasonably priced biologic medications is rising as chronic illnesses become more common. Adoption is also accelerated by government cost-containment initiatives and supportive regulatory frameworks. Another driver of growth in emerging economies is improved access […]